Versant Capital Management’s Halozyme HALO Stock Holding History

Versant Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$133K	Buy	1,693 +460	+37%	+$31.4K	0.01%	792
2026 Q1	$79.7K	Hold	1,233	–	–	0.01%	973
2025 Q4	$83K	Hold	1,233	–	–	0.01%	834
2025 Q3	$90.4K	Buy	1,233 +57	+5%	+$3.79K	0.01%	755
2025 Q2	$61.2K	Buy	1,176 +738	+168%	+$42K	0.01%	876
2025 Q1	$27.9K	Hold	438	–	–	﹤0.01%	1145
2024 Q4	$20.9K	Buy	438 +417	+1,986%	+$21.4K	﹤0.01%	1012
2024 Q3	$1.2K	Hold	21	–	–	﹤0.01%	1705
2024 Q2	$1.1K	Hold	21	–	–	﹤0.01%	1653
2024 Q1	$854	Hold	21	–	–	﹤0.01%	1576
2023 Q4	$776	Hold	21	–	–	﹤0.01%	1578
2023 Q3	$802	Hold	21	–	–	﹤0.01%	1591
2023 Q2	$757	Buy	+21	New	+$716	﹤0.01%	1700

Other funds holding HALO

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

KWM

Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return

AAM

Augustine Asset Management Jacksonville, Florida $494M AUM 76.22% 1-Year Est. Return

Cooper Investors Melbourne, Victoria, Australia $218M AUM 0.39% 1-Year Est. Return

Versant Capital Management's HALO Position: Q2 2026 in Review

Versant Capital Management increased its Halozyme (HALO) stake by 37% in Q2 2026, buying an estimated $31.4K and bringing the position to 1,693 shares worth $133K. The position accounts for 0.01% of the portfolio, ranked #792.

Versant Capital Management first reported a position in HALO in Q2 2023 and has held it in 13 quarters since. 102 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Versant Capital Management held 1,693 shares of Halozyme worth $133K as of Q2 2026.
Versant Capital Management bought 460 Halozyme shares in Q2 2026, an estimated $31.4K.
Halozyme made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #792 holding.
Versant Capital Management first reported a position in Halozyme in Q2 2023 and has held it in 13 quarters since.
102 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.